Clinical Trial Update: CTS-1027 in Interferon-Naive Hepatitis C Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of CTS-1027 in interferon-naive hepatitis C patients has been completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• CTS-1027

Snippet

Sponsor: Conatus Pharmaceuticals Inc. | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2012-03-27